Travere Therapeutics
Travere Therapeutics is a Nasdaq-listed (TVTX) biopharmaceutical company headquartered in San Diego, California, that develops and commercialises therapies for people with rare kidney and metabolic diseases. The company traces its roots to Retrophin, founded in 2011, which renamed itself Travere Therapeutics in November 2020. Its marketed products are FILSPARI (sparsentan), approved for IgA nephropathy, and THIOLA and THIOLA EC (tiopronin) for cystinuria; it sold its bile acid products Cholbam and Chenodal to Mirum Pharmaceuticals in 2023. Eric Dube is president and chief executive officer, and the company reported 497 full-time employees in its annual report for 2025.
Key facts
| Legal Name | Travere Therapeutics, Inc. |
|---|---|
| Company Operating Status | Active |
| Full Address | 2nd Floor Palmerston House, Fenian Street Dublin 2, Ireland D02 WD37 |
| Previous Name | Retrophin, Inc. |
| Stock Symbol | TVTX |
| Ticker Symbol | TVTX |
| Wellfound ID | retrophin |
Open roles at Travere Therapeutics
- Senior Manager, Drug Safety & Pharmacovigilance
- Associate Director, Data Management
- Senior Manager, Statistical Programming
- Executive Director, Translational Medicine & Pediatric Planning
- Director, Medical Science Liaison - Metabolic
- Associate Director, Clinical Scientist
- Associate Director, Quality Assurance - Technical
- Senior Thought Leader Liaison (Southwest)
- Director, Scientific Communications - Medical Content (Sparsentan)
- Director, Specialty Pharmacy, Trade, & Distribution
- Associate Director, Search and Evaluation
- Director, Enterprise Infrastructure Engineering & Operations
Browse Travere Therapeutics roles by location: 🌍 Remote · San Diego, United States · Switzerland
Land a role at Travere Therapeutics
Every live role, the locations Travere Therapeutics hires across, and the company facts — all above.
An email the day Travere Therapeutics posts a role, a cover letter and résumé bullets tailored to each one, and one-click apply.
Get startedEmail & phone for Travere Therapeutics are shown to signed-in members. Sign in →